ARNEO: neoadjuvant degarelix + apalutamide before surgery for high-risk prostate cancer

被引：0
|
作者：
Fenner A.
机构：
[1] Nature Reviews Urology,
来源：
Nature Reviews Urology | 2022年 / 19卷 / 11期
关键词：
D O I：
10.1038/s41585-022-00664-4
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：634 / 634
相关论文
共 50 条
  • [21] Results of surgery for high-risk prostate cancer
    Joniau, Steven
    Tosco, Lorenzo
    Briganti, Alberto
    Vanden Broeck, Thomas
    Gontero, Paolo
    Karnes, R. Jeffrey
    Spahn, Martin
    Van Poppel, Hein
    [J]. CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 342 - 348
  • [22] High-Risk Prostate Cancer: Radiation or Surgery?
    Stephans, K.
    Tendulkar, R.
    Reddy, C.
    Stephenson, A.
    Klein, E.
    Kupelian, P.
    Ciezki, J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S371 - S371
  • [23] The role of surgery for high-risk prostate cancer
    Ucer, Oktay
    Muezzinoglu, Talha
    [J]. UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2014, 13 (01): : 21 - 24
  • [24] Influences on androgen deprivation therapy prescribing before surgery in high-risk prostate cancer
    Dunsmore, Jennifer
    Duncan, Eilidh
    Maclennan, Sara J.
    N'Dow, James
    Cornford, Philip
    Esperto, Francesco
    Pavan, Nicola
    Ribal, Maria J.
    Roobol, Monique J.
    Skolarus, Ted A.
    Maclennan, Steven
    [J]. BJUI COMPASS, 2024, 5 (09): : 874 - 884
  • [25] Neoadjuvant mitoxantrone and docetaxel for high-risk localized prostate cancer
    Garzotto, M
    Myrthue, A
    Higano, CS
    Beer, TM
    [J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2006, 24 (03) : 254 - 259
  • [26] Neoadjuvant and adjuvant chemotherapy for high-risk localized prostate cancer
    Nakabayashi M.
    Oh W.K.
    [J]. Current Treatment Options in Oncology, 2004, 5 (5) : 349 - 355
  • [27] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    John Thoms
    Jayant S. Goda
    Alexender R. Zlotta
    Neil E. Fleshner
    Theodorus H. van der Kwast
    Stéphane Supiot
    Padraig Warde
    Robert G. Bristow
    [J]. Nature Reviews Clinical Oncology, 2011, 8 : 107 - 113
  • [28] Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer
    Thoms, John
    Goda, Jayant S.
    Zlotta, Alexendre R.
    Fleshner, Neil E.
    van der Kwast, Theodorus H.
    Supiot, St Phane
    Warde, Padraig
    Bristow, Robert G.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (02) : 107 - 113
  • [29] A New Chapter in Neoadjuvant Therapy for High-risk Prostate Cancer?
    Krafft, Ulrich
    Hadaschik, Boris A.
    Lueckerath, Katharina
    Herrmann, Ken
    [J]. EUROPEAN UROLOGY, 2024, 85 (03)
  • [30] The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer
    L Tosco
    A Laenen
    A Briganti
    P Gontero
    R J Karnes
    M Albersen
    P J Bastian
    P Chlosta
    F Claessens
    F K Chun
    W Everaerts
    C Gratzke
    M Graefen
    B Kneitz
    G Marchioro
    R S Salas
    B Tombal
    T Van den Broeck
    L Moris
    A Battaglia
    H van der Poel
    J Walz
    A Bossi
    G De Meerleer
    K Haustermans
    H Van Poppel
    M Spahn
    S Joniau
    [J]. Prostate Cancer and Prostatic Diseases, 2017, 20 : 407 - 412
12345